Moneycontrol PRO

you are here: HomeNewsBusinessCNBC-TV18 CommentsBiocon-Mylan start phase-3 global trials for drug Glargine

SHOW NAMES

Trending Topics

business

Biocon-Mylan start phase-3 global trials for drug Glargine

The size of Glargine is expected to be around USD 3-4 billion globally.

first published: Sep 17, 2014 11:47 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

SOBO to Bandra: Why Only South Mumbai Residents Call Bandra a Downgrade | The Tenant
Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell
Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347